161 related articles for article (PubMed ID: 26750774)
1. Comparative Analysis of Real-Time Polymerase Chain Reaction Methods to Typing HLA-B*57:01 in HIV-1-Positive Patients.
Falasca F; Dello Russo C; Mora B; Pirazzoli A; Fantauzzi A; Navarra P; Pizzuti A; De Vito C; Antonelli G; Turriziani O
AIDS Res Hum Retroviruses; 2016 Jul; 32(7):654-7. PubMed ID: 26750774
[TBL] [Abstract][Full Text] [Related]
2. Validation of two commercial real-time PCR assays for rapid screening of the HLA-B*57:01 allele in the HIV clinical laboratory.
Avidor B; Girshengorn S; Giladi L; Israel S; Katz R; Turner D
J Virol Methods; 2016 Nov; 237():18-24. PubMed ID: 27546346
[TBL] [Abstract][Full Text] [Related]
3. Rapid and Reliable Genotyping of HLA-B*57:01 in Four Chinese Populations Using a Single-Tube Duplex Real-Time Polymerase Chain Reaction Assay.
Han M; Kang X; Liu Z; Zhang T; Li Y; Chen C; Wang H
AIDS Res Hum Retroviruses; 2017 Jul; 33(7):711-717. PubMed ID: 28346841
[TBL] [Abstract][Full Text] [Related]
4. First external quality assurance program of the Italian HLA-B*57:01 Network assessing the performance of clinical virology laboratories in HLA-B*57:01 testing.
Meini G; Dello Russo C; Allice T; Barresi R; D'Arrigo R; Falasca F; Lipsi MR; Paolucci S; Zanussi S; Antonetti R; Baldanti F; Basaglia G; Bruzzone B; Polilli E; Ghisetti V; Pucillo LP; Turriziani O; Pirazzoli A; Navarra P; Zazzi M
J Clin Virol; 2016 May; 78():1-3. PubMed ID: 26946153
[TBL] [Abstract][Full Text] [Related]
5. Novel sensitive, specific and rapid pharmacogenomic test for the prediction of abacavir hypersensitivity reaction: HLA-B*57:01 detection by real-time PCR.
Dello Russo C; Lisi L; Lofaro A; Di Giambenedetto S; Federico B; Madeddu G; Salerno M; Mura MS; Pirazzoli A; de Luca A; Cauda R; Navarra P
Pharmacogenomics; 2011 Apr; 12(4):567-76. PubMed ID: 21521028
[TBL] [Abstract][Full Text] [Related]
6. Detection of HLA-B*57:01 by real-time PCR: implementation into routine clinical practice and additional validation data.
Dello Russo C; Lisi L; Fabbiani M; Gagliardi D; Fanti I; Di Giambenedetto S; Cauda R; Navarra P
Pharmacogenomics; 2014 Feb; 15(3):319-27. PubMed ID: 24533711
[TBL] [Abstract][Full Text] [Related]
7. Comparison of methods for in-house screening of HLA-B*57:01 to prevent abacavir hypersensitivity in HIV-1 care.
De Spiegelaere W; Philippé J; Vervisch K; Verhofstede C; Malatinkova E; Kiselinova M; Trypsteen W; Bonczkowski P; Vogelaers D; Callens S; Ruelle J; Kabeya K; De Wit S; Van Acker P; Van Sandt V; Emonds MP; Coucke P; Sermijn E; Vandekerckhove L
PLoS One; 2015; 10(4):e0123525. PubMed ID: 25874872
[TBL] [Abstract][Full Text] [Related]
8. Abacavir adverse reactions related with HLA-B*57: 01 haplotype in a large cohort of patients infected with HIV.
Quiros-Roldan E; Gardini G; Properzi M; Ferraresi A; Carella G; Marchi A; Malagoli A; Focà E; Castelli F
Pharmacogenet Genomics; 2020 Oct; 30(8):167-174. PubMed ID: 32453265
[TBL] [Abstract][Full Text] [Related]
9. High Frequency of Human Leukocyte Antigen-B*57:01 Allele Carriers among HIV-Infected Patients in Serbia.
Siljic M; Salemovic D; Cirkovic V; Pesic-Pavlovic I; Todorovic M; Ranin J; Dragovic G; Jevtovic D; Stanojevic M
Intervirology; 2017; 60(1-2):43-47. PubMed ID: 28772259
[TBL] [Abstract][Full Text] [Related]
10. Development of HLA-B*57:01 Genotyping Real-Time PCR with Optimized Hydrolysis Probe Design.
Jung HS; Tsongalis GJ; Lefferts JA
J Mol Diagn; 2017 Sep; 19(5):742-754. PubMed ID: 28732216
[TBL] [Abstract][Full Text] [Related]
11. Use of the HCP5 single nucleotide polymorphism to predict hypersensitivity reactions to abacavir: correlation with HLA-B*5701.
Rodríguez-Nóvoa S; Cuenca L; Morello J; Córdoba M; Blanco F; Jiménez-Nácher I; Soriano V
J Antimicrob Chemother; 2010 Aug; 65(8):1567-9. PubMed ID: 20534626
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of HLA-B*57:01 allele in Argentinean HIV-1 infected patients.
Moragas M; Belloso WH; Baquedano MS; Gutierrez MI; Bissio E; Larriba JM; Fay F; Aulicino P; Gurevich JM; Yaunguzian MF; Maldonado AC; Falistocco C; Sen L; Mangano A
Tissue Antigens; 2015 Jul; 86(1):28-31. PubMed ID: 25922880
[TBL] [Abstract][Full Text] [Related]
13. HLA-B*5701 frequency in Chilean HIV-infected patients and in general population.
Poggi H; Vera A; Lagos M; Solari S; Rodríguez P L; Pérez CM
Braz J Infect Dis; 2010; 14(5):510-2. PubMed ID: 21221482
[TBL] [Abstract][Full Text] [Related]
14. External quality assessment of HLA-B*5701 reporting: an international multicentre survey.
Hammond E; Almeida CA; Mamotte C; Nolan D; Phillips E; Schollaardt TA; Gill MJ; Angel JB; Neurath D; Li J; Giulivi T; McIntyre C; Koultchitski G; Wong B; Reis M; Rachlis A; Cole DE; Chew CB; Neifer S; Lalonde R; Roger M; Jeanneau A; Mallal S
Antivir Ther; 2007; 12(7):1027-32. PubMed ID: 18018760
[TBL] [Abstract][Full Text] [Related]
15. HLA- B*5701 Allele in HIV-infected Indian Children and its Association with Abacavir Hypersensitivity.
Manglani MV; Gabhale YR; Lala MM; Sekhar R; More D
Indian Pediatr; 2018 Feb; 55(2):140-141. PubMed ID: 29242412
[TBL] [Abstract][Full Text] [Related]
16. [Correlation, in previously treated HIV-1 positive patients, between hypersensitivity reaction to abacavir and the presence of the HLA-B*5701 allele].
Pérez Prior N; Rocher Milla A; Soler Company E; Flores Cid J; Sarria Chust B
Farm Hosp; 2009; 33(3):155-60. PubMed ID: 19712599
[TBL] [Abstract][Full Text] [Related]
17. Human leukocyte antigen (HLA) and pharmacogenetics: screening for HLA-B*57:01 among human immunodeficiency virus-positive patients from southern Alberta.
Berka N; Gill JM; Liacini A; O'Bryan T; Khan FM
Hum Immunol; 2012 Feb; 73(2):164-7. PubMed ID: 22197535
[TBL] [Abstract][Full Text] [Related]
18. HCP5 rs2395029 is a rapid and inexpensive alternative to HLA-B*57:01 genotyping to predict abacavir hypersensitivity reaction in Spain.
Zubiaur P; Saiz-Rodríguez M; Villapalos-García G; Navares-Gómez M; Koller D; Abad-Santos F
Pharmacogenet Genomics; 2021 Apr; 31(3):53-59. PubMed ID: 33044391
[TBL] [Abstract][Full Text] [Related]
19. A sensitive and rapid alternative to HLA typing as a genetic screening test for abacavir hypersensitivity syndrome.
Martin AM; Krueger R; Almeida CA; Nolan D; Phillips E; Mallal S
Pharmacogenet Genomics; 2006 May; 16(5):353-7. PubMed ID: 16609367
[TBL] [Abstract][Full Text] [Related]
20. Reducing hypersensitivity reactions with HLA-B*5701 genotyping before abacavir prescription: clinically useful but is it cost-effective in Singapore?
Kapoor R; Martinez-Vega R; Dong D; Tan SY; Leo YS; Lee CC; Sung C; Ng OT; Archuleta S; Teo YY
Pharmacogenet Genomics; 2015 Feb; 25(2):60-72. PubMed ID: 25461248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
